Tuesday, February 26, 2013

Rape Of Adopted Ohio Kids Unusual, Haunting Case - KHQ Right Now

TROY, Ohio (AP) - The one-story, brick ranch-style home blends into the working-class neighborhood along Nutmeg Square in this western Ohio city, offering no signs of the terrible secrets it once concealed.

Its former owner will return to court in Dayton on Tuesday to be sentenced for guilty pleas to child rape and related charges in a haunting case that experts call unusual because the perpetrator was an adoptive father and the victims were three boys in his care. The pleas have all but ensured he will spend the rest of his life in prison.

The 40-year-old man, whom The Associated Press isn't naming to protect the children's identities, said in an interview that he had been a foster parent, youth basketball coach and substitute teacher for years without any problems. He said he didn't adopt the boys with bad intentions.

"I always wanted to protect kids," he said during one of two interviews at the Miami County Jail. "Somewhere along the line, things went wrong."

In an era of stunning cases of sexual abuse of young boys by respected authority figures ? priests, Boy Scout leaders, an assistant coach at a famed college football program ? the repeated rapes of boys by an adoptive father who also arranged for two other men to rape one adopted son shocked his unsuspecting neighbors, investigators and children's services officials.

"It was just devastating to hear about. It's really sad for the kids," said April Long, a mother of three who was their next-door neighbor. She and other neighbors say they didn't suspect anything; the children played outside, and the man did neighborly things like pick up their mail or mow their lawn when they were away.

"You think: 'What could I have done? Is there something we missed that we should have seen?'" Long said, gazing at the home from her front porch lined with children's bicycles.

The single man was a foster parent for six other children before he began adopting children in the past three years. He adopted a brother and sister and an unrelated boy, and was in the process of adopting another boy, all ages 9 to 12, when authorities arrested him a year ago Sunday following an undercover sting that began when a detective looked into an online posting about "taboo sex."

Ohio officials don't believe there has been a comparable case in the state in recent years, and media reports over the past five years show only a handful of reported cases nationally in which adoptive fathers sexually abused children in their care. Child abuse by adoptive fathers is much rarer than by biological fathers, or by other male relatives and non-relatives, federal studies have indicated.

"This isn't a typical situation. It certainly isn't typical of people seeking adoption," said David Finkelhor, director of the Crimes Against Children Research Center at the University of New Hampshire. "Most abusers of this sort have an interest in a child during a certain period of their development. They are looking for opportunities where they can get access to the kids. They don't want to have custodial responsibility."

Fostering and adopting children meant passing background checks and other scrutiny, with home studies and follow-up visits by social workers.

"There can be terrible, horrific instances that no one at any level of government or the adoption system foresaw," Benjamin Johnson, spokesman for the Ohio Department of Job and Family Services, said of the case. "That can be a very difficult thing to reconcile ... and we think about that a lot."

The private adoption agency, Dayton-based Action Inc., has said little about the case other than to deny wrongdoing. The state reviewed its operations and noted some procedural violations but no reason to suspend or revoke the agency's license. All the children had been in Texas foster care before coming to Ohio through the agency, one of many that work through interstate agreements to find homes for some of the more than 100,000 children in foster care awaiting adoption at any given time in the United States.

The adoptive father said the three children appeared to be doing so well, he was asked by an agency employee to take a fourth.

The children were involved in sports, school and church and played with other children. They went trick-or-treating ? snapshots from two Halloweens ago show the boys dressed as Green Lantern and Star Wars' Darth Maul and the girl as a princess. They had Xboxes, Wiis and other games and toys at home.

"I loved my kids and wanted the best for them," the man said.

He said he had been sexually abused as a child by a close family member and blames that for his feeling that he wasn't doing anything wrong when he began taking the boys into his bed in what he claimed was a way of showing love.

"I never forced the boys to do anything," he said. "That might not mean anything to anyone else, but it's important to me."

But his explanation doesn't account for subsequently inviting a man to their Troy home to rape one of the boys, and then taking the same boy to another man's home to be raped. He agreed that was wrong, although he stressed that he didn't prostitute the boy by getting anything in return.

Apparently, no child ever hinted at any problem when separated from him by case workers for interviews.

"I guess they just liked it there," the man said.

Police reported that when they interviewed the boy, then age 10, who had also been raped by the two other men, he began shaking, after initially refusing to confirm that anything wrong had happened.

He told police he "didn't want to be taken from this home and separated from his new brothers and sister," a police report stated.

After the man was arrested, the 9-year-old boy who hadn't been adopted yet was returned to Texas social services authorities, while the other three were placed in foster care in Ohio.

At a pretrial hearing last November, a child psychologist testified about some three dozen therapy sessions he had had with the 10-year-old boy, the Dayton Daily News reported.

"It is so traumatic within the security of my office, when he's laying on a sofa, hugging a bear, to talk about these things," said Gregory Ramey of The Children's Medical Center of Dayton.

The adoptive father has already been sentenced here to at least 60 years in prison. In Dayton, he is expected to be sentenced to at least 50 years, to run concurrently.

He said he agreed to plead guilty in hopes of sparing the children from having to testify, that it "was the last good thing I could do for them." In a jail interview, his eyes teared up and his voice choked as he said he was sorry for the pain he had caused them.

In a letter from jail, he wrote: "I've been able to protect my kids from everything and everyone, except myself."

Source: http://www.khq.com/story/21327751/rape-of-adopted-ohio-kids-unusual-haunting-case

westminster kennel club dog show

U-M study challenges notion of using Herceptin only for HER2-positive breast cancer

U-M study challenges notion of using Herceptin only for HER2-positive breast cancer [ Back to EurekAlert! ] Public release date: 26-Feb-2013
[ | E-mail | Share Share ]

Contact: Nicole Fawcett
nfawcett@umich.edu
734-764-2220
University of Michigan Health System

Breast cancer stem cells express HER2, even in 'negative' tumors, study finds

ANN ARBOR, Mich. New research from the University of Michigan Comprehensive Cancer Center finds that the protein HER2 plays a role even in breast cancers that would traditionally be categorized as HER2-negative and that the drug Herceptin, which targets HER2, may have an even greater role for treating breast cancer and preventing its spread.

About 20 percent of women with breast cancer have tumors labeled HER2-positive. And since the drug Herceptin has come on the scene, it has had a tremendous impact on survival for these women, particularly when it is given in the adjuvant setting, after surgery to remove the primary cancer. The new findings have potential implications for an additional 65 percent of women with breast cancer.

A recent study based on new analyses of old data found some tumors were incorrectly categorized as HER2-positive and as a result those women received adjuvant Herceptin. It turns out, they benefited as much from the treatment as woman with actual HER2-positive cancer.

"We now provide a molecular explanation for the surprising finding that adjuvant Herceptin benefited some women with HER2-negative breast cancer. If this is confirmed in clinical trials, it could alter our approach to breast cancer treatment," says study author Max S. Wicha, M.D., distinguished professor of oncology and director of the U-M Comprehensive Cancer Center.

At this point, patients with HER2-negative breast cancer are not advised to take Herceptin.

The explanation is that HER2 is selectively expressed in the cancer stem cells of many HER2-negative breast tumors. Because the stem cells represent such a small number of cells in a tumor, the amount of HER2 is not high enough to meet the threshold for a HER2-positive cancer.

The researchers had previously shown HER2 plays an important role in cancer stem cells the small number of cells in a tumor that fuel its growth and spread. These cells represent 1 percent to 5 percent of all the cells in a tumor. They are resistant to current chemotherapy and radiation treatments but since they express HER2, they are effectively targeted by Herceptin.

Further, the researchers in this new study found that for tumors classified as HER2-negative, HER2 levels were higher in bone metastases compared to the primary breast tumor. Bone is the most frequent site to which breast cancer spreads.

The researchers administered Herceptin to mice with these bone lesions and found that it was most effective when given early, when tumors were small or mere "micrometastases." In these cases, Herceptin almost completely blocked the tumors from growing. When the drug was given later, after tumors were established, it had little effect.

"We have shown that the bone microenvironment induces HER2 expression in these tumors. If Herceptin can target bone micrometastases, then administering it to patients before metastases develop could help reduce tumor recurrence," says study author Hasan Korkaya, Ph.D., research assistant professor of internal medicine at the U-M Medical School.

The implications of this finding are that we need cancer treatments that target the small number of cancer stem cells in addition to traditional chemotherapies that eliminate the bulk tumor cells. This means that merely looking at whether a tumor shrinks is not good enough to determine whether the treatment will have long term benefit.

"This work has very significant implications for how we have developed adjuvant therapies. The idea of using drugs that cause tumors to shrink, which has been the accepted paradigm for developing therapies, is flawed. Our work suggests that adjuvant therapies will need to target the cancer stem cell population. Eliminating cancer stem cells by effective adjuvant therapies should prevent tumor recurrence, ultimately resulting in more cures," Wicha says.

###

A large randomized clinical trial sponsored by the National Institutes of Health is currently open at U-M and other sites across the country to address this question. Patients whose tumors are not considered HER2-positive by classic testing should not receive Herceptin outside of this trial. For information about the trial, call the U-M Cancer AnswerLine at 800-865-1125.

Additional authors: Suthinee Ithimakin, Kathleen C. Day, Fayaz Malik, Qin Zen, Scott J. Dawsey, Tom F. Bersano-Begey, Ahmed A. Quraishi, Kathleen Woods Ignatoski, Stephanie Daignault, April Davis, Christopher L. Hall, Nallasivam Palanisamy, Amber N. Heath, Nader Tawakkol, Tahra K. Luther, Shawn G. Clouthier, Whitney A. Chadwick, Mark L. Day, Celina G. Kleer, Dafydd G. Thomas, Daniel F. Hayes

Funding: National Cancer Institute grants CA129765 and CA101860; Breast Cancer Research Foundation; Komen for the Cure; Taubman Institute at the University of Michigan; Fashion Footwear Charitable Foundation of New York/QVC Presents Shoes-On-Sale; Stand Up to Cancer grant SU2C-AACR DT0409

Disclosure: Max Wicha has financial holdings in OncoMed Pharmaceuticals, receives support from Dompe and MedImmune and serves on the scientific advisory board of Veristem; Hasan Korkaya receives research support from MedImmune; Daniel Hayes has received research support from Pfizer, Novartis and Veridex and holds stock options for his role on the scientific advisory board for OncImmune.

Reference: Cancer Research, published online Feb. 26, 2013

Resources:

U-M Cancer AnswerLine, 800-865-1125
U-M Comprehensive Cancer Center, www.mcancer.org
Clinical trials at U-M, www.UMClinicalStudies.org/cancer


[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


U-M study challenges notion of using Herceptin only for HER2-positive breast cancer [ Back to EurekAlert! ] Public release date: 26-Feb-2013
[ | E-mail | Share Share ]

Contact: Nicole Fawcett
nfawcett@umich.edu
734-764-2220
University of Michigan Health System

Breast cancer stem cells express HER2, even in 'negative' tumors, study finds

ANN ARBOR, Mich. New research from the University of Michigan Comprehensive Cancer Center finds that the protein HER2 plays a role even in breast cancers that would traditionally be categorized as HER2-negative and that the drug Herceptin, which targets HER2, may have an even greater role for treating breast cancer and preventing its spread.

About 20 percent of women with breast cancer have tumors labeled HER2-positive. And since the drug Herceptin has come on the scene, it has had a tremendous impact on survival for these women, particularly when it is given in the adjuvant setting, after surgery to remove the primary cancer. The new findings have potential implications for an additional 65 percent of women with breast cancer.

A recent study based on new analyses of old data found some tumors were incorrectly categorized as HER2-positive and as a result those women received adjuvant Herceptin. It turns out, they benefited as much from the treatment as woman with actual HER2-positive cancer.

"We now provide a molecular explanation for the surprising finding that adjuvant Herceptin benefited some women with HER2-negative breast cancer. If this is confirmed in clinical trials, it could alter our approach to breast cancer treatment," says study author Max S. Wicha, M.D., distinguished professor of oncology and director of the U-M Comprehensive Cancer Center.

At this point, patients with HER2-negative breast cancer are not advised to take Herceptin.

The explanation is that HER2 is selectively expressed in the cancer stem cells of many HER2-negative breast tumors. Because the stem cells represent such a small number of cells in a tumor, the amount of HER2 is not high enough to meet the threshold for a HER2-positive cancer.

The researchers had previously shown HER2 plays an important role in cancer stem cells the small number of cells in a tumor that fuel its growth and spread. These cells represent 1 percent to 5 percent of all the cells in a tumor. They are resistant to current chemotherapy and radiation treatments but since they express HER2, they are effectively targeted by Herceptin.

Further, the researchers in this new study found that for tumors classified as HER2-negative, HER2 levels were higher in bone metastases compared to the primary breast tumor. Bone is the most frequent site to which breast cancer spreads.

The researchers administered Herceptin to mice with these bone lesions and found that it was most effective when given early, when tumors were small or mere "micrometastases." In these cases, Herceptin almost completely blocked the tumors from growing. When the drug was given later, after tumors were established, it had little effect.

"We have shown that the bone microenvironment induces HER2 expression in these tumors. If Herceptin can target bone micrometastases, then administering it to patients before metastases develop could help reduce tumor recurrence," says study author Hasan Korkaya, Ph.D., research assistant professor of internal medicine at the U-M Medical School.

The implications of this finding are that we need cancer treatments that target the small number of cancer stem cells in addition to traditional chemotherapies that eliminate the bulk tumor cells. This means that merely looking at whether a tumor shrinks is not good enough to determine whether the treatment will have long term benefit.

"This work has very significant implications for how we have developed adjuvant therapies. The idea of using drugs that cause tumors to shrink, which has been the accepted paradigm for developing therapies, is flawed. Our work suggests that adjuvant therapies will need to target the cancer stem cell population. Eliminating cancer stem cells by effective adjuvant therapies should prevent tumor recurrence, ultimately resulting in more cures," Wicha says.

###

A large randomized clinical trial sponsored by the National Institutes of Health is currently open at U-M and other sites across the country to address this question. Patients whose tumors are not considered HER2-positive by classic testing should not receive Herceptin outside of this trial. For information about the trial, call the U-M Cancer AnswerLine at 800-865-1125.

Additional authors: Suthinee Ithimakin, Kathleen C. Day, Fayaz Malik, Qin Zen, Scott J. Dawsey, Tom F. Bersano-Begey, Ahmed A. Quraishi, Kathleen Woods Ignatoski, Stephanie Daignault, April Davis, Christopher L. Hall, Nallasivam Palanisamy, Amber N. Heath, Nader Tawakkol, Tahra K. Luther, Shawn G. Clouthier, Whitney A. Chadwick, Mark L. Day, Celina G. Kleer, Dafydd G. Thomas, Daniel F. Hayes

Funding: National Cancer Institute grants CA129765 and CA101860; Breast Cancer Research Foundation; Komen for the Cure; Taubman Institute at the University of Michigan; Fashion Footwear Charitable Foundation of New York/QVC Presents Shoes-On-Sale; Stand Up to Cancer grant SU2C-AACR DT0409

Disclosure: Max Wicha has financial holdings in OncoMed Pharmaceuticals, receives support from Dompe and MedImmune and serves on the scientific advisory board of Veristem; Hasan Korkaya receives research support from MedImmune; Daniel Hayes has received research support from Pfizer, Novartis and Veridex and holds stock options for his role on the scientific advisory board for OncImmune.

Reference: Cancer Research, published online Feb. 26, 2013

Resources:

U-M Cancer AnswerLine, 800-865-1125
U-M Comprehensive Cancer Center, www.mcancer.org
Clinical trials at U-M, www.UMClinicalStudies.org/cancer


[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


Source: http://www.eurekalert.org/pub_releases/2013-02/uomh-usc022113.php

iCarly banana republic gap Victoria Secret Bath And Body Works Dicks Sporting Good office max

Sunday, February 24, 2013

Best Buy Offers $100 Discount on Windows 8 Touchscreen PCs

Best Buy Offers $100 Discount on Windows 8 Touchscreen PCs

Beginning Sunday, Best Buy will be offering a $100 discount on all touchscreen Windows 8 PCs. Best Buy sales of touchscreens has not been keeping up with national averages and hope to boost sales with the $100 discounted offer to consumers?.. and to make their customers happy of course. big grin

The retailer said Friday it decided to launch the promotion after recent surveys the company conducted showed the consumers who bought touchscreen Windows 8 devices were significantly happier than those who bought PCs with a typical screen.

Comments

Posted by Al 4:12 PM (CST)??

Source: http://www.hardocp.com/news/2013/02/23/best_buy_offers_100_discount_on_windows_8_touchscreen_pcs/

mickelson how to tie a tie sweet potato recipes the sound of music celebration church new york auto show 2012 tulsa

Google Is Making Moves To Seriously Disrupt Groupon (GRPN, GOOG)

Business Insider writes, Groupon's stock has been crawling back from the abyss, with the company now worth about $3.8 billion. That's still less than the $6 billion Google offered for the daily-deals site shortly before Groupon went public. And now Google seems like it's moving to kill off Groupon by making ads for discounts and deals easier than ever to buy. Larry Kim, founder and CTO of WordStream, an online-marketing technology company, noticed that Google's Offers ads?deals broadly similar to Groupon's email discounts?were now available to anyone using Google's upgraded AdWords dashboard for managing ads. Rob?

Continue reading Google Is Making Moves To Seriously Disrupt Groupon (GRPN, GOOG) at Business Insider

Source: http://technewstube.com/business-insider/175017/google-is-making-moves-to-seriously-disrupt-groupon-grpn-goog/

barney frank kim richards robert hegyes mary louise parker mary louise parker cher morgellons

Africa Mongolia to Host UN World Environment Day 2013

  • Asia Times - Saturday 23rd February, 2013

    By Alexandra Kazakova Last year's violence in the town of Janaozen has created a significantly more oppressive environment in Kazakhstan, according to human rights defenders and analysts ...

  • Rate of US-Russian nuke disarmament slows

    Asia Times - Saturday 23rd February, 2013

    By Carey L Biron WASHINGTON - Although the United States and Russia have massively reduced their collective number of nuclear weapons since the heyday of the Cold War, the rate of that reduction ...

  • Russia-Uzbekistan rowjeopardizes bilateral ties

    Asia Times - Saturday 23rd February, 2013

    investigation, O'zdunorbita continuously violated national legislation by illicitly operating 48 base stations in various parts of the country, including 24 stations based out of Tashkent. ...

  • Russias gas grip worries US senator

    Asia Times - Saturday 23rd February, 2013

    By Margarita Assenova United States Senator Richard Lugar has urged the Obama administration to break Russia's energy monopoly in Europe and called on congress to lift limitations on ...

  • Crime pays in Kyrgyzstan

    Asia Times - Saturday 23rd February, 2013

    By Chris Rickleton BISHKEK - One morning last year in Bishkek, Kyrgyzstan, Dilnoza awoke to find her brand-new Toyota Corolla missing. She knew immediately whom to call, and it wasn't her ...

  • Russia plays alongwith Sakhalin pipeline project

    Asia Times - Saturday 23rd February, 2013

    By Sergei Blagov Russia's gas monopoly, Gazprom, has apparently ruled out the possibility of building a subsea Sakhalin-Japan natural gas pipeline. However, the continuation of talks on ...

  • Tamerlane through Central Asian eyes

    Asia Times - Saturday 23rd February, 2013

    Tamerlane through Central Asian eyes The Legendary Biographies of Tamerlane: Islam and Heroic Apocrypha in Central Asia by Ron SelaReviewed by Dmitry Shlapentokh This well-researched book ...

  • CIS nations set date for free-trade zone

    Asia Times - Saturday 23rd February, 2013

    By Sergei Blagov The latest top-level meeting of the oldest post-Soviet grouping, the Commonwealth of Independent States (CIS), pledged to enact their free-trade arrangements next year. However, ...

  • Siberia placed to be the new Middle East

    Asia Times - Saturday 23rd February, 2013

    originates from a volatile region with a lion's share of the supply passing through narrow waterways that could easily be sealed off to tankers. More than any other market factors, it is ...

  • Salafists challenge Kazakh future

    Asia Times - Saturday 23rd February, 2013

    Salafists challenge Kazakh future By Jacob Zenn Kazakhstan has experienced a rise in militant activity carried out by Salafist groups on its territory and periphery since late 2011. The ...

  • Kyrgyzstan flirts with Russian ambitions

    Asia Times - Saturday 23rd February, 2013

    By Dmitry Shlapentokh Recent agreements signed between Russian President Vladimir Putin and his Kyrgyz Republic counterpart, Almazbek Atambayev, are replete with mutual benefits. Russia affirmed ...

  • Jewelry-making part of family day at McClung Museum

    General Sources - Saturday 23rd February, 2013

    McClung Museum invites the public to glimpse treasures from the past and create their own jewelry during a free family day at the University of Tennessee this ...

  • Azerbaijan and Turkey can produce anti-tank missiles

    News.Az - Saturday 23rd February, 2013

    Azerbaijan can produce UMTAS and OMTAS anti-tank missiles with Turkey, Turkish defence industry delegation told APA at 11th International Defence Exhibition (IDEX - 2013) exhibition. Azerbaijan is ...

  • Sport in Azerbaijan developed after Heydar Aliyevs advent to power - MP

    News.Az - Saturday 23rd February, 2013

    Azerbaijani sport has achieved great success in the international arena. The statement came from the deputy executive secretary of the ruling party, MP Mubariz Gurbanli at a presentation of book ...

  • Azerbaijan claims for hosting Islamic sport games in 2017

    News.Az - Saturday 23rd February, 2013

    Azerbaijan has turned into one of the world sport centers able to host major sport events. The statement came from Minister of Youth and Sports of Azerbaijan Azad Rahimov speaking at the ...

  • Azeri boxers reach semifinal of Strandja tournament in Bulgaria

    News.Az - Saturday 23rd February, 2013

    Four Azerbaijani boxers have qualified for the semifinal of the Strandja tournament in Bulgaria. On the way to the final, Elvin Isayev weighing in at 64kg, Munasib Mammadov at 49kg, Javid ...

  • Azerbaijan Macedonia sign memo on audit services

    News.Az - Saturday 23rd February, 2013

    AzerTAj reports. The memorandum is aimed at fostering closer relations between Azerbaijan and Macedonia, as well as improving the quality of audit ...

  • Azerbaijan to form Labour Resources Development Agency

    News.Az - Saturday 23rd February, 2013

    The Ministry of Labour and Social Protection considers establishing the Labour Resources Development Agency. A draft regulation of the agency has already been developed and will be updated in ...

  • KSA signs water and sewerage deal with Azerbaijan

    Construction Week Online - Friday 22nd February, 2013

    The Saudi Fund for Development and Azerbaijan have signed the protocol of negotiations under the draft credit agreement on allocation of $35m for renovation and expansion of water supply and ...

  • Russian military told to fix deficiencies

    Middle East Times - Friday 22nd February, 2013

    Random checks of the Russian armed forces revealed a number of systemic shortcomings, General Staff chief Valery Gerasimov said. Combat alert checks were carried out in the Central and South ...

  • Source: http://www.turkmenistannews.net/index.php/sid/212780411/scat/929bcf2071e81801

    powerball weather forecast national weather service weather channel Rivals

    Saturday, February 23, 2013

    Vicksburg mayor appears in court wearing handcuffs, jumpsuit

    Vicksburg Mayor Paul Winfield appeared in a federal court room Thursday in handcuffs and an orange inmate jumpsuit.

    Winfield is facing federal bribery charges and is accused of seeking a $10,000 payment for a city contract.

    Click to read more.

    Source: http://www.nbcnews.com/id/50894007/ns/local_news-jackson_ms/

    khloe and lamar oklahoma city thunder sunoco titanic ii babe ruth new jersey nets nba playoff schedule

    Apple pulls 'Prop 2' from upcoming proxy vote, says disappointed with court decision

    After a U.S. federal judge sided with David Einhorn's Greenlight Capital in a lawsuit seeking the injunction of proposal vote scheduled to be held at Apple's upcoming shareholders meeting, the Cupertino, Calif., company removed the contentious "Prop 2" item from the docket.


    Apple announced in a statement on Friday that it will be pulling Prop 2 from its annual meeting slated to take place on Feb. 27, reports AllThingsD. Einhorn sought to block a vote on the proposal as it contained an article which revokes the ability of Apple's board members to issue preferred stock, instead putting that power into the hands of shareholders.

    Apple's statement:

    We are disappointed with the court?s ruling. Proposal #2 is part of our efforts to further enhance corporate governance and serve our shareholders? best interests. Unfortunately, due to today?s decision, shareholders will not be able to vote on Proposal #2 at our annual meeting next week.

    With the announcement, Apple is conforming to Judge Richard Sullivan's decision issued earlier today.

    Einhorn wants Apple to issue so-called "iPrefs," or perpetual preferred stock that would pay out a quarterly 50 cents dividend equating to $2 per year. He suggests Apple could extend and enhance the program over time to ultimately offer five iPrefs per share of common stock, doubling the current dividend rate to return some $47 billion of company's swelling $137 billion cash hoard.

    While Prop 2 has been removed from next week's annual meeting, Apple is not obligated to issue the iPrefs. It is unclear what the company plans to do regarding Einhorn's pressure, but thus far it has been loath to give in to the hedge fund manager's demands.

    Source: http://appleinsider.com.feedsportal.com/c/33975/f/616168/s/28dd5839/l/0Lappleinsider0N0Carticles0C130C0A20C220Capple0Epulls0Eprop0E20Efrom0Eupcoming0Eproxy0Evote/story01.htm

    masters winner instagram facebook mike wallace mike wallace chicago cubs split pea soup recipe the client list